Search research articles
Contact Us
Filters
Showing results (11-20 of 71) with videos related to
Page
of 8
Sort By:
Journal of Cutaneous Medicine and Surgery
|
March 19, 2026
Current and Future Management of Chronic Hand Eczema in Canada: Evolving Treatment Paradigms
Jensen Yeung, Melinda Gooderham, H Chih-Ho Hong, et al.
Journal of Cutaneous Medicine and Surgery
|
July 1, 2005
Kikuchi-Fujimoto's necrotizing lymphadenitis in association with discoid lupus erthematosus: a case report
Shane G Silver, H Chih-Ho Hong, Patricia T Ting, et al.
Journal of the American Academy of Dermatology
|
May 9, 2026
A practical framework for treating-to-target in chronic hand eczema
Jensen Yeung, Melinda Gooderham, H Chih-Ho Hong, et al.
The Journal of Dermatological Treatment
|
March 20, 2019
Efficacy and safety of guselkumab, administered with a novel patient-controlled injector (One-Press), for moderate-to-severe psoriasis: results from the phase 3 ORION study
Laura K Ferris, Elyssa Ott, Jingzhi Jiang, et al.
Dermatology and Therapy
|
April 9, 2026
Perceptions and Experiences of Patients Across All Skin Tones Living with Psoriasis in Canada
H Chih-Ho Hong, Tessa Carr, Frankie Tai, et al.
Journal of Cutaneous Medicine and Surgery
|
November 28, 2022
Proactive Topical Maintenance Treatment of Psoriasis: Subanalysis of Canadian Patients in the Phase III PSO-LONG Trial
H Chih-Ho Hong, David N Adam, Jason K Rivers, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
July 31, 2007
A comprehensive approach to the recognition, diagnosis, and severity-based treatment of focal hyperhidrosis: recommendations of the Canadian Hyperhidrosis Advisory Committee
Nowell Solish, Vince Bertucci, Alain Dansereau, et al.
Dermatology and Therapy
|
July 30, 2024
Efficacy of Upadacitinib and Dupilumab on Achieving Stringent and Composite Skin and Itch Outcomes: an Indirect Comparison of Adults with Moderate-to-Severe Atopic Dermatitis
April W Armstrong, H Chih-Ho Hong, Brian M Calimlim, et al.
Dermatology and Therapy
|
February 9, 2024
Speed and Cumulative Responses According to Body Regions in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Ixekizumab (Interleukin-17A Antagonist) versus Guselkumab (Interleukin-23p19 Inhibitor)
Melinda Gooderham, Ronald Vender, Jeffrey Crowley, et al.
American Journal of Clinical Dermatology
|
May 27, 2026
Safety and Tolerability of Ruxolitinib Cream in Adolescents with Mild-to-Moderate Atopic Dermatitis: Results From a 1-Year, Phase III, Open-Label Study
Joel C Joyce, H Chih-Ho Hong, Dareen D Siri, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 71) with videos related to
Sort By:
Page
of 8
Journal of Cutaneous Medicine and Surgery
|
March 19, 2026
Current and Future Management of Chronic Hand Eczema in Canada: Evolving Treatment Paradigms
Jensen Yeung, Melinda Gooderham, H Chih-Ho Hong, et al.
Journal of Cutaneous Medicine and Surgery
|
July 1, 2005
Kikuchi-Fujimoto's necrotizing lymphadenitis in association with discoid lupus erthematosus: a case report
Shane G Silver, H Chih-Ho Hong, Patricia T Ting, et al.
Journal of the American Academy of Dermatology
|
May 9, 2026
A practical framework for treating-to-target in chronic hand eczema
Jensen Yeung, Melinda Gooderham, H Chih-Ho Hong, et al.
The Journal of Dermatological Treatment
|
March 20, 2019
Efficacy and safety of guselkumab, administered with a novel patient-controlled injector (One-Press), for moderate-to-severe psoriasis: results from the phase 3 ORION study
Laura K Ferris, Elyssa Ott, Jingzhi Jiang, et al.
Dermatology and Therapy
|
April 9, 2026
Perceptions and Experiences of Patients Across All Skin Tones Living with Psoriasis in Canada
H Chih-Ho Hong, Tessa Carr, Frankie Tai, et al.
Journal of Cutaneous Medicine and Surgery
|
November 28, 2022
Proactive Topical Maintenance Treatment of Psoriasis: Subanalysis of Canadian Patients in the Phase III PSO-LONG Trial
H Chih-Ho Hong, David N Adam, Jason K Rivers, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
July 31, 2007
A comprehensive approach to the recognition, diagnosis, and severity-based treatment of focal hyperhidrosis: recommendations of the Canadian Hyperhidrosis Advisory Committee
Nowell Solish, Vince Bertucci, Alain Dansereau, et al.
Dermatology and Therapy
|
July 30, 2024
Efficacy of Upadacitinib and Dupilumab on Achieving Stringent and Composite Skin and Itch Outcomes: an Indirect Comparison of Adults with Moderate-to-Severe Atopic Dermatitis
April W Armstrong, H Chih-Ho Hong, Brian M Calimlim, et al.
Dermatology and Therapy
|
February 9, 2024
Speed and Cumulative Responses According to Body Regions in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Ixekizumab (Interleukin-17A Antagonist) versus Guselkumab (Interleukin-23p19 Inhibitor)
Melinda Gooderham, Ronald Vender, Jeffrey Crowley, et al.
American Journal of Clinical Dermatology
|
May 27, 2026
Safety and Tolerability of Ruxolitinib Cream in Adolescents with Mild-to-Moderate Atopic Dermatitis: Results From a 1-Year, Phase III, Open-Label Study
Joel C Joyce, H Chih-Ho Hong, Dareen D Siri, et al.
Page
of 8